News
News
Q2 2022
In the current challenging satiation at local clinical trials market, Almedis strictly fulfills its obligations in ongoing projects.

  • Almedis representative, as part of an ACTO delegation, visited Kazakhstan to assess the current state and potential of the clinical trials market in this country.
  • In a phase I oncology trial, all centers are initiated, and the first patient has received an investigational product.
  • The previously suspended enrollment of patients in a non-interventional study in oncohematology has been resumed.
Q1 2022
  • Starting from the end of February 2022, Almedis makes every effort to ensure the rights and well-being of patients participating in ongoing trials and takes part in the work of ACTO to monitor the situation and find optimal solutions to support clinical trials in Russia.
  • A notice of completion in Russia of an international phase 4 IIT comparing different regimens of antithrombotic therapy in pregnant women has been submitted to the Ministry of Health of the Russian Federation.
  • The study of comorbidities in patients with chronic viral infection was completed.
  • The study to evaluate antibiotic use in children with vaccine-controlled viral infections has started.
  • The study to evaluate HIV drug resistance in Russia has started.
Q3-Q4 2021
  • The study of glycemic control in patients with diabetes mellitus completed, database has been closed.
  • The study of real data with forecasting trends in oncology has completed.
  • The study of the prevalence of oncogenic viral infections among patients at various clinics has completed, database has been closed.
  • Patient recruitment completed and data for interim analysis has been prepared in a hemophilia study.
  • The study of comorbidities in patients with chronic viral infection has started.
  • Phase 1 oncology study has started.
  • Results of previously completed study in neurology (treatment of non-specific low back pain) has been published at clinicaltrials.gov.
Q2 2021
  • ALMEDIS took part in the educational program of the Russian Society of Clinical Oncology (RUSSCO) for young scientists, holding a webinar "Research planning and problem setting"
  • The study in oncohematology (multiple myeloma) has started
  • The study in oncology (breast cancer) has started
  • BE study was carried out
Q1 2021
  • The study in neurology (treatment of non-specific low back pain) has been completed
  • The study of real world data with forecasting trends in oncology has started
  • The study of the prevalence of oncogenic viral infections among patients at various clinics has started
  • The study of intestinal microflora in newborns has been completed